Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Concepción Gómez, Luma Melo, David Martí‐Aguado, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. 1, pp. 1-15
Open Access | Times Cited: 13

Showing 13 citing articles:

Diagnostic Performance of Noninvasive Tests in Patients with MetALD in a Health Check-up Cohort
Joo Hyun Oh, Sang Bong Ahn, Seon Cho, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 8
Alcohol-associated liver disease: Epidemiology and management
Helena Hernández-Évole, Natalia Jiménez, Elisa Pose, et al.
Annals of Hepatology (2023) Vol. 29, Iss. 1, pp. 101162-101162
Open Access | Times Cited: 21
KASL Clinical Practice Guidelines for Noninvasive Tests to Assess Liver Fibrosis in Chronic Liver Disease
Mi Na Kim, Ji Won Han, Jihyun An, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. Suppl, pp. S5-S105
Open Access | Times Cited: 5
Liver diseases: epidemiology, causes, trends and predictions
Can Gan, Yuan Yuan, Haiyuan Shen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Current and future treatment for alcoholic‐related liver diseases
Eileen L. Yoon, Won Kim
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 8, pp. 1218-1226
Open Access | Times Cited: 11
Liver stiffness as a dynamic predictor of decompensation and mortality in alcohol-related liver disease
Majeed M. A. Ali
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 3
Expansion of effector regulatory T cells in steroid responders of severe alcohol-associated hepatitis
Min Woo Kang, Soon Kyu Lee, Eun Ji Jang, et al.
Liver Transplantation (2024) Vol. 30, Iss. 9, pp. 877-886
Closed Access | Times Cited: 2
Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development
Kenneth Blum, Eric R. Braverman, Mark S. Gold, et al.
INNOSC Theranostics and Pharmacological Sciences (2024) Vol. 7, Iss. 2, pp. 1472-1472
Open Access | Times Cited: 2
Alcohol consumption and the risk of liver disease: a nationwide, population-based study
Sang Yi Moon, Minkook Son, Yeo Wool Kang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Non-Invasive Biomarkers for Differentiating Alcohol Associated Hepatitis from Acute Decompensation in Patients with ALD
Mina Ignat, Horia Ştefănescu
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3747-3747
Open Access | Times Cited: 1
The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study
Keungmo Yang, Sung Hwan Kim, Hyun Yang, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 929-942
Open Access
ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validation
Song Li, Shuo Huang, Honghao Yan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Rifaximin treatment in patients with severe alcoholic hepatitis: A multicenter, randomized controlled, open-label, pilot trial
Do Seon Song, Jin Mo Yang, Young Kul Jung, et al.
Annals of Hepatology (2024), pp. 101749-101749
Open Access
Page 1

Scroll to top